Intercept Pharmaceuticals did a re-analysis of the data from their fatty liver disease clinical trial, and guess what, they say it worked.

I can only imagine how cutting Adam Feuerstein will be about that, cuz, ya know anyone who re-analyzes data is clearly trying to make a failed clinical trial look good -- right?

Oh wait -- the positive article about the company is on..... the website he writes for -- and he wrote the article.